| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |